BerandaALK-B • CPH
add
ALK-Abello A/S
Tutup sebelumnya
kr 146,70
Rentang hari
kr 145,20 - kr 147,90
Rentang tahun
kr 123,80 - kr 185,60
Kapitalisasi pasar
29,72Â M DKK
Volume Rata-Rata
214,93Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
CPH
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (DKK) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 1,50Â M | 11,45% |
Biaya operasional | 749,00Â jt | 15,23% |
Laba bersih | 170,00Â jt | 21,43% |
Margin laba bersih | 11,34 | 8,93% |
Penghasilan per saham | 0,80 | 14,29% |
EBITDA | 287,00Â jt | 21,22% |
Tarif pajak efektif | 14,14% | — |
Neraca
Total aset
Total liabilitas
| (DKK) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 589,00Â jt | 24,26% |
Total aset | 8,25Â M | 22,60% |
Total liabilitas | 2,87Â M | 26,06% |
Total ekuitas | 5,37 M | — |
Saham yang beredar | 221,19 jt | — |
Harga terhadap nilai buku | 6,04 | — |
Tingkat pengembalian aset | 6,85% | — |
Tingkat pengembalian modal | 8,68% | — |
Arus Kas
Perubahan kas bersih
| (DKK) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 170,00Â jt | 21,43% |
Kas dari operasi | 453,00Â jt | 38,96% |
Kas dari investasi | -1,08Â M | -1.172,94% |
Kas dari pembiayaan | 654,00Â jt | 1.823,53% |
Perubahan kas bersih | 33,00Â jt | -87,64% |
Arus kas bebas | -747,88Â jt | -713,01% |
Tentang
ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products with 67% of its revenue coming from sales in Europe. Wikipedia
Didirikan
1923
Situs
Karyawan
2.753
